15/07/2026
💜 Let’s help our XLH kids in New Zealand! 🤝
PHARMAC is considering funding Crysvita (Burosumab) for children with XLH, and your consumer comment could help make a real difference.
The Rare Disorders Advisory Committee meeting is scheduled for 29 July 2026. While there isn’t a formal cut-off date for consumer submissions, submitting your comment as soon as possible is encouraged.
Anyone with lived experience of XLH—including patients, carers, family members, healthcare professionals, and patient advocacy organisations from around the world—are encouraged to share their experience to help PHARMAC understand the impact of XLH and the importance of equitable access to treatment.
Together, let’s stand behind our New Zealand XLH community and help give their children the best chance of accessing treatment.
💜 Every voice matters.
Submit your consumer comment:
https://www.pharmac.govt.nz/about/expert-advice/hearing-lived-experiences/consumer-relations-team
View the meeting agenda:
https://livenews.co.nz/2026/05/29/agenda-for-july-2026-rare-disorders-advisory-committee-meeting/
XLH Australia Inc - Public Page
XLHCommunity
https://www.instagram.com/p/Dau4smSyKuE/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==